Early Vascular Aging (EVA): New Directions in Cardiovascular Protection
Editat de Michael Hecht Olsen, Peter M Nilsson, Stephane Laurenten Limba Engleză Hardback – 5 aug 2015
The book presents a novel approach to the problem of cardiovascular disease, showing it in relation to great vessels disease and revealing a comprehensive approach to the problem of increased rigidity of the great vessels, its causes, and further consequences.
Information provided is accompanied by online access to a supplemental website with video clips of anatomic specimens, cardiac imaging, and surgical procedures.
- Introduces the latest information on early vascular aging (EVA), complete with summaries of recent evidence and guidelines for relevant risk factor control
- Ideal reference for the study of vascular aging, pulse wave velocity, arteriosclerosis, EVA, arterial stiffness, vascular, PWV biomarkers, and cardiovascular disease
- Contains all the relevant information available from different fields of knowledge (from basic biology to epidemiology) in regard to EVA
- Provides evidence that leads to a new target for interventions, early vascular aging (EVA) in subjects with early onset increased arterial stiffness
- Includes online access to a supplemental website with video clips of anatomic specimens, cardiac imaging, and surgical procedures
Preț: 685.26 lei
Preț vechi: 860.58 lei
-20% Nou
Puncte Express: 1028
Preț estimativ în valută:
131.14€ • 136.23$ • 108.93£
131.14€ • 136.23$ • 108.93£
Carte tipărită la comandă
Livrare economică 27 ianuarie-10 februarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780128013878
ISBN-10: 0128013877
Pagini: 376
Dimensiuni: 216 x 276 x 23 mm
Greutate: 1.29 kg
Editura: ELSEVIER SCIENCE
ISBN-10: 0128013877
Pagini: 376
Dimensiuni: 216 x 276 x 23 mm
Greutate: 1.29 kg
Editura: ELSEVIER SCIENCE
Public țintă
Specialists and researchers of hypertension and cardiology, preventive cardiology, diabetology and internal and general medicine, geriatricians, physiologists and experts in image medicineCuprins
Chapter 1: Historical Aspects and Biology of Aging
Chapter 2: Cellular and Molecular Determinant of Arterial Aging
Chapter 3: Changing Demography of Europe-Greying Populations
Chapter 4: Population-Based Studies
Chapter 5: Lessons from Amsterdam Growth and Health Longitudinal Study
Chapter 6: History and Findings of the BLSA
Chapter 7: Changes in Peripheral Blood Pressure with Normal and Accelerated Aging
Chapter 8: Changes in Arterial Stiffness with Normal and Accelerated Aging
Chapter 9: Changes in Central Hemodynamics, Wave Reflection and Heart-Vessel Coupling with Normal and Accelerated Aging
Chapter 10: Early Aging of Endothelial Function and Platelet-Vessel Wall Interaction
Chapter 11: The Cross-Talk between the Macro and Microcirculation
Chapter 12: Blood Pressure Variability
Chapter 13: Early Vascular Aging in Children with Low Birth Weight and/or Prematurity
Chapter 14: Age-Induced Endothelial Dysfunction and Intima-Media Thickening
Chapter 15: Glucose Metabolism, Diabetes, and the Arterial Wall
Chapter 16: Chronic Inflammation and Antherosclerosis
Chapter 17: Early and Late Stages of Chronic Kidney Disease in relation to Arterial Changes
Chapter 18: Polycystic Ovarian Syndrome
Chapter 19: Early and Late Stages of Brain Damage
Chapter 20: Telomere Biology and Aging
Chapter 21: Traditional versus new models of Risk Prediction
Chapter 22: Imaging Biomarkers: Aortic Stiffness and Carotid IMT as Predictors of CV Disease
Chapter 23: Genetic Markers in Prediction of CV Disease
Chapter 24: Vascular Aging and CV Disease
Chapter 25: Lifestyle Intervention: What works?
Chapter 26: Targeting BP Lowering and Sympathetic Nervous System
Chapter 27: Targeting Central BP through the Macro-Microcirculation Cross-Talk
Chapter 28: Treatment of Abnormalities in Glucose and Lipid Metabolism
Chapter 29: New Drugs under Development for Cardiovascular Prevention
Chapter 30: Interventions to retard Biological Aging to be Explored
Chapter 31: Immuniziation, Vaccines and Immunomodulation
Chapter 2: Cellular and Molecular Determinant of Arterial Aging
Chapter 3: Changing Demography of Europe-Greying Populations
Chapter 4: Population-Based Studies
Chapter 5: Lessons from Amsterdam Growth and Health Longitudinal Study
Chapter 6: History and Findings of the BLSA
Chapter 7: Changes in Peripheral Blood Pressure with Normal and Accelerated Aging
Chapter 8: Changes in Arterial Stiffness with Normal and Accelerated Aging
Chapter 9: Changes in Central Hemodynamics, Wave Reflection and Heart-Vessel Coupling with Normal and Accelerated Aging
Chapter 10: Early Aging of Endothelial Function and Platelet-Vessel Wall Interaction
Chapter 11: The Cross-Talk between the Macro and Microcirculation
Chapter 12: Blood Pressure Variability
Chapter 13: Early Vascular Aging in Children with Low Birth Weight and/or Prematurity
Chapter 14: Age-Induced Endothelial Dysfunction and Intima-Media Thickening
Chapter 15: Glucose Metabolism, Diabetes, and the Arterial Wall
Chapter 16: Chronic Inflammation and Antherosclerosis
Chapter 17: Early and Late Stages of Chronic Kidney Disease in relation to Arterial Changes
Chapter 18: Polycystic Ovarian Syndrome
Chapter 19: Early and Late Stages of Brain Damage
Chapter 20: Telomere Biology and Aging
Chapter 21: Traditional versus new models of Risk Prediction
Chapter 22: Imaging Biomarkers: Aortic Stiffness and Carotid IMT as Predictors of CV Disease
Chapter 23: Genetic Markers in Prediction of CV Disease
Chapter 24: Vascular Aging and CV Disease
Chapter 25: Lifestyle Intervention: What works?
Chapter 26: Targeting BP Lowering and Sympathetic Nervous System
Chapter 27: Targeting Central BP through the Macro-Microcirculation Cross-Talk
Chapter 28: Treatment of Abnormalities in Glucose and Lipid Metabolism
Chapter 29: New Drugs under Development for Cardiovascular Prevention
Chapter 30: Interventions to retard Biological Aging to be Explored
Chapter 31: Immuniziation, Vaccines and Immunomodulation
Recenzii
"... it builds on the evidence in previous chapters, eventually signing off with a discussion of possible means to retard vascular aging...a good start on the expanding field of EVA. Score: 82 - 3 Stars" --Doody's